Open AccessThe brain‐penetrant ATM inhibitor, AZD1390, promotes axon regeneration and functional recovery in preclinical models of spinal cord injury
Author(s) -
Ahmed Zubair,
Tuxworth Richard I.
Publication year - 2022
Publication title -
clinical and translational medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.125
H-Index - 1
ISSN - 2001-1326
DOI - 10.1002/ctm2.962
Subject(s) - axon , spinal cord injury , neuroscience , dorsal root ganglion , neurite , central nervous system , spinal cord , dna damage , regeneration (biology) , myelin , dna repair , microbiology and biotechnology , medicine , biology , pharmacology , cancer research , in vitro , dna , biochemistry